Uric Acid Predicts Long-Term Cardiovascular Risk in Type 2 Diabetes but Does Not Mediate the Benefits of Fenofibrate: the FIELD Study

FIELD investigators, Jacob Y. Cao, Boris Waldman, Rachel O’Connell, Marja-Riitta Taskinen, Anthony C. Keech

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalDiabetes, obesity and metabolism
Volume22
Issue number8
Pages (from-to)1388-1396
Number of pages9
ISSN1462-8902
DOIs
Publication statusPublished - Aug 2020
MoE publication typeA1 Journal article-refereed

Fields of Science

  • 3121 Internal medicine
  • cardiovascular disease
  • drug mechanism
  • type 2 diabetes
  • CORONARY-HEART-DISEASE
  • MIDDLE-AGED MEN
  • METABOLIC SYNDROME
  • MORTALITY
  • HYPERURICEMIA
  • ATORVASTATIN
  • METAANALYSIS
  • THERAPY
  • EVENTS
  • WOMEN

Cite this